pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
fosdesdenosine sipalabenamide
fosdesdenosine sipalabenamide [INN]
Metastatic Melanoma
$NCNANuCana plc
0 catalysts
Phase 2
foselutoclax
foselutoclax [INN]
Diabetic Macular Edema
Unity Biotechnology Inc
0 catalysts
Phase 2
fosigotifator sodium tromethamine
Unspecified Central Nervous System Disorders
Calico Life Sciences LLC
0 catalysts
← prev
page 39 of 53
next →
131
Pain89
Neurology1
Phase 2
fostroxacitabine bralpamide hydrochloride
Hepatocellular Carcinoma
Medivir AB
0 catalysts
Phase 2
froniglutide
froniglutide [INN]
Duchenne Muscular Dystrophy
ImmunoForge Co Ltd
0 catalysts
Phase 2
fulzerasib
fulzerasib [INN]
Metastatic Colorectal Cancer
GenFleet Therapeutics (Shanghai) Inc
0 catalysts
Phase 2
furaprevir
furaprevir [INN]
Hepatitis C
TaiGen Biotechnology Co Ltd
0 catalysts
Phase 2
fusidic acid
Burkholderia pseudomallei Infections (Melioidosis)
Elongation factor G
Aceragen Inc
0 catalysts
Phase 2
galicaftor
Cystic Fibrosis
Cystic fibrosis transmembrane conductance regulator
$SIONSionna Therapeutics, Inc.
0 catalysts
Phase 2
garetatug rezetecan
garetatug rezetecan [INN]
Gastric Cancer
Jiangsu Hengrui Pharmaceuticals Co Ltd
0 catalysts
Phase 2
gedeptin
Nasopharyngeal Cancer
$GOVXGeoVax Labs, Inc.
0 catalysts
Phase 2
gemlapodect
Stammering (Stuttering)
Noema Pharma AG
0 catalysts
Phase 2
gemogenovatucel-T
Vigil (gemogenovatucel-T)
Endometrial Cancer
Gradalis Inc
0 catalysts
Phase 2
genistein
Pulmonary Fibrosis
Humanetics Corp
0 catalysts
Phase 2
gilavebexagene anvuparvovec
Tay-Sachs Disease
University of Massachusetts
0 catalysts
Phase 2
glatiramer acetate ER
glatiramer acetate
Primary Progressive Multiple Sclerosis (PPMS)
Mapi Pharma Ltd
0 catalysts
Phase 2
glecirasib
glecirasib [INN]
Non-Small Cell Lung Cancer
Jacobio Pharmaceuticals Group Co Ltd
0 catalysts
Phase 2
gocatamig
Small-Cell Lung Cancer
$MRKMerck & Co., Inc.
0 catalysts
Phase 2
golidocitinib
Peripheral T-Cell Lymphomas (PTCL)
Tyrosine-protein kinase JAK1
Dizal Pharmaceutical Co Ltd
0 catalysts
Phase 2
grapiprant
Osteoarthritis Pain
Prostaglandin E2 receptor EP4 subtype
AskAt Inc
0 catalysts
Phase 2
guadecitabine sodium
Fallopian Tube Cancer
Astex Pharmaceuticals Inc
0 catalysts
Phase 2
gumarontinib
gumarontinib [INN]
Non-Small Cell Lung Cancer
Shanghai Haihe Biopharma Co Ltd
0 catalysts
Phase 2
hemoporfin
cholangiocarcinoma
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
0 catalysts
Phase 2
hemorrhagic fever vaccine
Hemorrhagic Fever
Envelope glycoproteinNucleoprotein
US Army Medical Research & Materiel Command
0 catalysts
Phase 2
huMNC2-CAR22
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Minerva Biotechnologies Corp
0 catalysts
Phase 2
huMNC2-CAR44
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Minerva Biotechnologies Corp
0 catalysts
Phase 2
hydroxyprogesterone caproate
Hydroxyprogesterone Caproate (hydroxyprogesterone caproate [INN])
Premature Labor (Tocolysis)
$LPCNLipocine Inc.
0 catalysts
Phase 2
hymecromone
Primary Sclerosing Cholangitis
Halo Biosciences Inc
0 catalysts
Phase 2
iCIP
LiPlacis (cisplatin)
Metastatic Breast Cancer
Chosa Oncology AB
0 catalysts
Phase 2
iLution travoprost
travoprost
Ocular Hypertension
Prostaglandin F2-alpha receptor
$GKOSGLAUKOS Corp
0 catalysts